2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Thrombocytopenia
6
Leukemia
4
Hematologic Neoplasms
3
Hematologic Diseases
3
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Venous Thromboembolism
1
Transfusion Reaction
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Multiple Sclerosis
1
Motor Activity
1
Lymphoma, T-Cell
1
Lymphoma, B-Cell
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Biphenotypic, Acute
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
fludarabine
4
Cyclophosphamide
4
Specimen Handling
2
Nivolumab
2
Natalizumab
2
Interferon beta-1b
2
Fingolimod Hydrochloride
2
Blood Specimen Collection
2
teriflunomide
1
nabiximols
1
gadobutrol
1
gadobenic acid
1
cabozantinib
1
Surveys and Questionnaires
1
Respiratory Therapy
1
Registries
1
Platinum Compounds
1
Platelet Transfusion
1
Plasma Exchange
1
Phlebotomy
1
OM 89
1
Mn-PyC3A
1
Medical Marijuana
1
Magnetic Resonance Spectroscopy
1
Magnetic Resonance Imaging
1
Ipilimumab
1
Interferon beta-1a
1
Injections
1
Gadolinium DTPA
1
Fish Oils
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Multiple Sclerosis
×
Platelet Transfusion
×
Clear all
NCT02601131
2016-11-29
Post-transfusion Platelet Count
Region Skane
Completed
80 enrolled